267 related articles for article (PubMed ID: 32241275)
21. Default Mode Network Functional Connectivity in Early and Late Mild Cognitive Impairment: Results From the Alzheimer's Disease Neuroimaging Initiative.
Lee ES; Yoo K; Lee YB; Chung J; Lim JE; Yoon B; Jeong Y;
Alzheimer Dis Assoc Disord; 2016; 30(4):289-296. PubMed ID: 26840545
[TBL] [Abstract][Full Text] [Related]
22. Systematic analysis to identify transcriptome-wide dysregulation of Alzheimer's disease in genes and isoforms.
Fan C; Chen K; Zhou J; Wong PP; He D; Huang Y; Wang X; Ling T; Yang Y; Zhao H
Hum Genet; 2021 Apr; 140(4):609-623. PubMed ID: 33140241
[TBL] [Abstract][Full Text] [Related]
23. The Clinical Course of Early and Late Mild Cognitive Impairment.
Lin SY; Lin PC; Lin YC; Lee YJ; Wang CY; Peng SW; Wang PN
Front Neurol; 2022; 13():685636. PubMed ID: 35651352
[TBL] [Abstract][Full Text] [Related]
24. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
[TBL] [Abstract][Full Text] [Related]
25. Identification of potential blood biomarkers for early diagnosis of Alzheimer's disease through RNA sequencing analysis.
Shigemizu D; Mori T; Akiyama S; Higaki S; Watanabe H; Sakurai T; Niida S; Ozaki K
Alzheimers Res Ther; 2020 Jul; 12(1):87. PubMed ID: 32677993
[TBL] [Abstract][Full Text] [Related]
26. The trend of disruption in the functional brain network topology of Alzheimer's disease.
Fathian A; Jamali Y; Raoufy MR;
Sci Rep; 2022 Sep; 12(1):14998. PubMed ID: 36056059
[TBL] [Abstract][Full Text] [Related]
27. Self-calibrated brain network estimation and joint non-convex multi-task learning for identification of early Alzheimer's disease.
Lei B; Cheng N; Frangi AF; Tan EL; Cao J; Yang P; Elazab A; Du J; Xu Y; Wang T
Med Image Anal; 2020 Apr; 61():101652. PubMed ID: 32059169
[TBL] [Abstract][Full Text] [Related]
28. Atrophy of the cholinergic regions advances from early to late mild cognitive impairment.
Lai YL; Hsu FT; Yeh SY; Kuo YT; Lin HH; Lin YC; Kuo LW; Chen CY; Liu HS;
Neuroradiology; 2024 Apr; 66(4):543-556. PubMed ID: 38240769
[TBL] [Abstract][Full Text] [Related]
29. Unveiling clusters of RNA transcript pairs associated with markers of Alzheimer's disease progression.
Arefin AS; Mathieson L; Johnstone D; Berretta R; Moscato P
PLoS One; 2012; 7(9):e45535. PubMed ID: 23029078
[TBL] [Abstract][Full Text] [Related]
30. Data-Limited Deep Learning Methods for Mild Cognitive Impairment Classification in Alzheimer's Disease Patients.
De Luna A; Marcia RF
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():2641-2646. PubMed ID: 34891795
[TBL] [Abstract][Full Text] [Related]
31. BMNet: A New Region-Based Metric Learning Method for Early Alzheimer's Disease Identification With FDG-PET Images.
Cui W; Yan C; Yan Z; Peng Y; Leng Y; Liu C; Chen S; Jiang X; Zheng J; Yang X
Front Neurosci; 2022; 16():831533. PubMed ID: 35281501
[TBL] [Abstract][Full Text] [Related]
32. Linking the association between circRNAs and Alzheimer's disease progression by multi-tissue circular RNA characterization.
Lo I; Hill J; Vilhjálmsson BJ; Kjems J
RNA Biol; 2020 Dec; 17(12):1789-1797. PubMed ID: 32618510
[TBL] [Abstract][Full Text] [Related]
33. Deep Learning and Risk Score Classification of Mild Cognitive Impairment and Alzheimer's Disease.
Nagaraj S; Duong TQ
J Alzheimers Dis; 2021; 80(3):1079-1090. PubMed ID: 33646166
[TBL] [Abstract][Full Text] [Related]
34. A novel joint HCPMMP method for automatically classifying Alzheimer's and different stage MCI patients.
Sheng J; Wang B; Zhang Q; Liu Q; Ma Y; Liu W; Shao M; Chen B
Behav Brain Res; 2019 Jun; 365():210-221. PubMed ID: 30836158
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Progression Toward Alzheimer's Disease Based on Evolutionary Weighted Random Support Vector Machine Cluster.
Bi XA; Xu Q; Luo X; Sun Q; Wang Z
Front Neurosci; 2018; 12():716. PubMed ID: 30349454
[TBL] [Abstract][Full Text] [Related]
36. c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease.
Jemimah S; AlShehhi A;
BMC Med Genomics; 2023 Oct; 16(Suppl 2):244. PubMed ID: 37833700
[TBL] [Abstract][Full Text] [Related]
37. Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer's disease patients.
Xiang S; Huang Z; Wang T; Han Z; Yu CY; Ni D; Huang K; Zhang J
BMC Med Genomics; 2018 Dec; 11(Suppl 6):115. PubMed ID: 30598117
[TBL] [Abstract][Full Text] [Related]
38. Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification.
Zhong H; Zhou X; Uhm H; Jiang Y; Cao H; Chen Y; Mak TTW; Lo RMN; Wong BWY; Cheng EYL; Mok KY; Chan ALT; Kwok TCY; Mok VCT; Ip FCF; Hardy J; Fu AKY; Ip NY
Alzheimers Dement; 2024 Apr; 20(4):2469-2484. PubMed ID: 38323937
[TBL] [Abstract][Full Text] [Related]
39. Sex influences the effects of APOE genotype and Alzheimer's diagnosis on neuropathology and memory.
Duarte-Guterman P; Albert AY; Barha CK; Galea LAM; On Behalf Of The Alzheimer's Disease Neuroimaging Initiative
Psychoneuroendocrinology; 2021 Jul; 129():105248. PubMed ID: 33962245
[TBL] [Abstract][Full Text] [Related]
40. A comprehensive analysis on preservation patterns of gene co-expression networks during Alzheimer's disease progression.
Ray S; Hossain SMM; Khatun L; Mukhopadhyay A
BMC Bioinformatics; 2017 Dec; 18(1):579. PubMed ID: 29262769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
